- £73.57bn
- £86.64bn
- £30.33bn
- 87
- 44
- 98
- 91
REG - GSK PLC - EMA accepts Arexvy filing for adults 50-59 at risk
AnnouncementREG - GSK PLC - European Commission authorises Omjjara in the EU
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - Haleon PLC GSK PLC - Holding(s) in Company
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - GSK completes sale of shares in Haleon plc
AnnouncementREG - GSK PLC - GSK announces intention to sell shares in Haleon
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Nucala approved in China for use in severe asthma
AnnouncementREG - GSK PLC - GSK enters agreement to acquire Aiolos Bio
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC GlaxoSK Capital PLC GlaxoSK Kabush.K GSK Capital B.V. - Publication of EMTN Suppl.Prospcts
AnnouncementREG - GSK PLC - Jemperli plus Zejula Trial Meets Endpoint
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Japan accepts Arexvy filing for at risk adults
AnnouncementREG - GSK PLC - Jemperli plus chemotherapy EU authorisation
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
Announcement